STAGE IV BLADDER CANCER AJCC V8
Clinical trials for STAGE IV BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of drugs takes on Hard-to-Treat bladder cancer
Disease control Not yet recruitingThis early-phase trial tests a combination of three drugs—enfortumab vedotin, pembrolizumab, and quemliclustat—in people with advanced bladder or urinary tract cancer that has spread or cannot be removed by surgery. The goal is to see if the combination is safe and effective. The…
Matched conditions: STAGE IV BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New strategy aims to eliminate residual bladder cancer after drug combo
Disease control Not yet recruitingThis early-phase trial tests whether adding radiation therapy or bladder removal surgery can safely eliminate remaining cancer in patients with advanced bladder cancer who have already responded to a drug combination. The study enrolls 12 adults with muscle-invasive bladder cance…
Matched conditions: STAGE IV BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC